R. H. Hall

3.3k total citations · 1 hit paper
73 papers, 2.4k citations indexed

About

R. H. Hall is a scholar working on Endocrinology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, R. H. Hall has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, 17 papers in Molecular Biology and 13 papers in Organic Chemistry. Recurrent topics in R. H. Hall's work include Vibrio bacteria research studies (18 papers), Escherichia coli research studies (15 papers) and Aquaculture disease management and microbiota (8 papers). R. H. Hall is often cited by papers focused on Vibrio bacteria research studies (18 papers), Escherichia coli research studies (15 papers) and Aquaculture disease management and microbiota (8 papers). R. H. Hall collaborates with scholars based in United States, Australia and United Kingdom. R. H. Hall's co-authors include Myron M. Levine, G Losonsky, D A Herrington, John J. Mekalanos, Robert K. Taylor, Mahendra H. Kothary, James P. Nataro, James B. Kaper, Ben D. Tall and Fernando Navarro‐García and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

R. H. Hall

69 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

1988 556 citations D A Herrington, R. H. Hall et al. The Journal of Experimental Medicine profile →

Peers

Countries citing papers authored by R. H. Hall

Since Specialization

Citations

This map shows the geographic impact of R. H. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. H. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. H. Hall more than expected).

Fields of papers citing papers by R. H. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. H. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. H. Hall. The network helps show where R. H. Hall may publish in the future.

Co-authorship network of co-authors of R. H. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of R. H. Hall. A scholar is included among the top collaborators of R. H. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. H. Hall. R. H. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers 2022 ·PLoS neglected tropical diseases ·Kirsten E. Wiens, Bárbara Jaúregui, Benjamin F. Arnold, (unknown), Djibril Wade, Kyla Hayford, (unknown), R. H. Hall, Henrik Salje, Isabel Rodríguez-Barraquer, Andrew S. Azman, Guy Vernet, Daniel T. Leung	10
2	Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection WithVibrio choleraeO1 El Tor 2016 ·Clinical Infectious Diseases ·Wilbur H. Chen, Mitchell B. Cohen, Beth D. Kirkpatrick, Rebecca C. Brady, David Galloway, Marc Gurwith, R. H. Hall, (unknown), Michael Lock, Douglas J. Haney, Caroline E. Lyon, Marcela F. Pasetti, Jakub K. Simon, Flóra Szabó, Sharon M. Tennant, Myron M. Levine	128
3	Enteric vaccines for pediatric use 2005 ·Vaccine ·Richard I. Walker, Lillian L. Van De Verg, R. H. Hall, Clare K. Schmitt, (unknown), Victoria Hale	3
4	Immunoblotting and Enzyme-Linked Immunosorbent Assay 2003 ·Humana Press eBooks ·(unknown), R. H. Hall	1
5	Identification of Escherichia coli O157:H7 and other enterohemorrhagic serotypes by EHEC- hly A targeting, strand displacement amplification, and fluorescence polarization 2002 ·Molecular and Cellular Probes ·Beilei Ge, Carolyn Larkin, Sun Hee Ahn, (unknown), Muh. Nasir, Jianghong Meng, R. H. Hall	13
6	Cloning, expression and characterization of the CHO cell elongating factor (Cef) from Vibrio cholerae O1 2002 ·Microbial Pathogenesis ·B. A. McCardell, Venugopal Sathyamoorthy, Jane M. Michalski, Sukadev Lavu, Mahendra H. Kothary, Jeffrey Livezey, James B. Kaper, R. H. Hall	5
7	Biosensor technologies for detecting microbiological foodborne hazards 2002 ·Microbes and Infection ·R. H. Hall	78
8	A PCR–ELISA for detecting Shiga toxin-producing Escherichia coli 2002 ·Microbes and Infection ·Beilei Ge, Shaohua Zhao, R. H. Hall, Jianghong Meng	30
9	Characterization of a 20-kDa pilus protein expressed by a diarrheogenic strain of non-O1/non-O139Vibrio cholerae 1998 ·FEMS Microbiology Letters ·Tanusree Sengupta, Ranjan K. Nandy, S. Mukhopadhyay, R. H. Hall, Venugopal Sathyamoorthy, Asoke C. Ghose	12
10	NDLTD: Encouraging International Collaboration in the Academy 1997 ·DESIDOC Journal of Library & Information Technology ·Edward A. Fox, R. H. Hall, Neill A. Kipp, John L. Eaton, Gail McMillan, Paul M. Mather	10
11	A search for cholera toxin (CT), toxin coregulated pilus (TCP), the regulatory element ToxR and other virulence factors in non-O1/non-O139Vibrio cholerae 1997 ·Microbial Pathogenesis ·Chandradipa Ghosh, Ranjan K. Nandy, (unknown), G. Balakrish Nair, R. H. Hall, Asoke C. Ghose	60
12	Biochemical and physiological characteristics of hlya, a pore-forming cytolysin of Vibrio cholerae serogroup O1 1997 ·Toxicon ·Venugopal Sathyamoorthy, James S. Huntley, Andrew C. Hall, R. H. Hall	6
13	SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Lisa A. Marshall, R. H. Hall, Julia Winkler, A M Badger, Brian Bolognese, Amy Roshak, (unknown), (unknown), Marie Chabot‐Fletcher, Jerry L. Adams	48
14	Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru 1992 ·Journal of Clinical Microbiology ·Augusto A. Franco, César González-Bonilla, Orin S. Levine, Rosanna Lagos, R. H. Hall, Stephen L. Hoffman, Mischka A. Moechtar, Eduardo Gotuzzo, Myron M. Levine, David M. Hone	22
15	Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model 1989 ·Vaccine ·Dharam P. Sharma, Connor Thomas, R. H. Hall, Myron M. Levine, Stephen R. Attridge	58
16	Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. breakdown → 1988 ·The Journal of Experimental Medicine ·D A Herrington, R. H. Hall, G Losonsky, John J. Mekalanos, Robert K. Taylor, Myron M. Levine	556
17	Morphological studies on fimbriae expressed by Vibrio cholerae 01 1988 ·Microbial Pathogenesis ·R. H. Hall, Pablo Vial, James B. Kaper, John J. Mekalanos, Myron M. Levine	58
18	Helping patients take their medicine. 1979 ·PubMed ·R. H. Hall	4
19	N⁶-(Δ²-Isopentenyl)adenosine: Its Occurrence as a Free Nucleoside in an Autonomous Strain of Tobacco Tissue 1972 ·PLANT PHYSIOLOGY ·(unknown), R. H. Hall	53
20	ACUTE TOXICITY OF INHALED THORIUM COMPOUNDS 1951 ·OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) ·R. H. Hall, (unknown), J.K. Scott, (unknown), L.T. Steadman, Herbert E. Stokinger	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact